Skip to content

Informing fresh versus standard Issue red cell management

INforming Fresh versus Old Red cell Management (INFORM): a large simple phase III randomized controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN08118744
Enrollment
31497
Registered
2012-02-16
Start date
2012-04-02
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Red blood cell transfusion Haematological Disorders Blood transfusion (without reported diagnosis)

Interventions

Patients requiring red blood cell transfusion will be randomized to one of the following conditions: 1. Freshest available red blood cells (experiment arm) 2. Standard-

Sponsors

McMaster University (Canada)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All adult patients (age >/= 18) will be included if: 1. Hospitalized at a participating centre (in-patient) 2. Undergoing a red cell transfusion

Exclusion criteria

Exclusion criteria: 1. Specific requirement for fresh blood (e.g., sickle cell disease, transfuion-dependent thalassemia, fresh cells ordered by care provider) 2. Pre-planned directed or autologous donation 3. Request for un-crossmatched blood 4. Anticipated massive transfusion as communicated from clinical area

Design outcomes

Primary

MeasureTime frame
In-hospital mortality

Secondary

MeasureTime frame
Time to event (death)

Countries

Australia, Canada, Israel, United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 8, 2026